Drug intelligence / Profile preview

Cur18

Development stage
Unknown
Lead developer
Kosmos
Administration
Oral
01

Overview

Cur18 is a next-generation curcumin-based nutraceutical supplement developed by Cosmos Health as part of its '18 Series' product line. It is formulated with a patented, turmeric-derived whole-spectrum extract that is standardized to approximately 50% curcuminoids and derived approximately 98.5% from turmeric, preserving the plant's natural matrix of curcuminoids, essential oils, and polar resins. This unique formulation enhances the absorption and bioavailability of curcumin through improved dispersion mechanisms. In a randomized, double-blind crossover pharmacokinetic study, Cur18 demonstrated up to 39-fold higher free curcumin bioavailability and 49.5-fold higher total curcumin AUC compared to standard 95% curcuminoid extracts. It is indicated for joint health, antioxidant support, and inflammation and mobility management.

Brand names
Cur18Cur-18Cur 18
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NF-κB15-LOX (Lysyl Oxidase)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on Cur18.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cur18.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call